Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
Condition(s):Diabetic Macular EdemaLast Updated:July 16, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Diabetic Macular EdemaLast Updated:July 16, 2013Completed
Condition(s):Macular Degeneration; Retinal DrusenLast Updated:October 28, 2021Completed
Condition(s):Branch Retinal Vein OcclusionLast Updated:November 13, 2014Completed
Condition(s):Retinitis Pigmentosa; Cystoid Macular EdemaLast Updated:January 23, 2020Completed
Condition(s):Diabetic Macular EdemaLast Updated:May 30, 2016Completed
Condition(s):Diabetic Macular OedemaLast Updated:June 23, 2010Completed
Condition(s):Age-Related Macular Degeneration; Diabetic Maculopathy; Central Serous ChorioretinopathyLast Updated:January 13, 2010Unknown status
Condition(s):Macular Degeneration, Senile; Laser Burn of Retina; Macular Degeneration Intermediate; Macular Degeneration, DryLast Updated:September 1, 2023Recruiting
Condition(s):Diabetic Macular Edema; Visual ImpairmentLast Updated:March 3, 2017Completed
Condition(s):Diabetic Macular EdemaLast Updated:March 19, 2014Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.